share_log

Needham Maintains Buy on Veracyte, Lowers Price Target to $27

Needham Maintains Buy on Veracyte, Lowers Price Target to $27

Needham维持对Veracyte的买入,将目标股价下调至27美元
Benzinga ·  05/08 08:14

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $33 to $27.

Needham分析师Mike Matson维持Veracyte(NASDAQ:VCYT)的买入评级,并将目标价格从33美元下调至27美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发